| ACT | Adaptive cell transfer |
| ANOVA | Analysis of variance |
| APLCNR | Apelin receptor |
| C3 | Complement component 3 |
| CAR | Chimeric antigen receptor |
| CCL | Chemokine antigen receptor |
| CD137 | Tumor necrosis factor receptor superfamily member 9 (TNFRSF9) |
| CD4+ cell | Cluster of differentiation 4-positive cell |
| CD8+ cell | Cluster of differentiation 8-positive cell |
| CRISPR | Clustered regularly interspaced short palindromic repeats |
| CTLA-4 | Cytotoxic T-lymphocyte-associated protein 4 |
| CX3CR1 | CX3C chemokine receptor |
| CXCL13 | Chemokine (C-X-C motif) ligand 13 |
| cyTOF | Mass cytometry |
| dMMR | Deficient DNA mismatch repair |
| EGFR | Epidermal growth factor receptor |
| EI | Electron impact |
| ESI | Electrospray ionization |
| GC | Gas chromatography |
| GCMB | Glial Cells Missing Transcription Factor 2 |
| GEO | Gene Expression Omnibus |
| GITR | Glucocorticoid-induced TNFR family-related gene |
| GZMK | Granzyme K |
| HOPE | High-tech Omics-based Patient Evaluation |
| IARC | International Agency for Research on Cancer |
| ICGC | International Cancer Genome Consortium |
| ICI | Immune checkpoint inhibitor |
| IDO | Indoleamine 2,3-dioxygenase |
| IFN | Interferon |
| IL | Interleukin |
| IL17RA | IL17 receptor A |
| irAE | Immune-related adverse event |
| LC | Liquid chromatography |
| LIHC | Liver hepatocellular carcinoma |
| MS | Mass spectrometry |
| MS/MS | Tandem mass spectrometry |
| MSI | Microsatellite instability |
| NGS | Next-generation sequencing |
| NIST | National Institute of Standards and Technology |
| NK | Natural killer cell |
| nSMase2 | Sphingomyelinase 2 |
| OX40 | Tumor necrosis factor receptor superfamily, member 4 (TNFRSF4) |
| PCA | Principal component analysis |
| PCR | Polymerase chain reaction |
| PD-1 | Programmed cell death protein 1 |
| PD-L1 | Programmed death-ligand 1 |
| PEG | Polyethylene glycol |
| PLA2G4A | Phospholipase A2 group IVA |
| PLS-DA | Partial least squares-discriminant analysis |
| POLE | Polymerase epsilon |
| PRF1 | Perforin 1 |
| PTGS2 | Prostaglandin-endoperoxide synthase 2 |
| PTPN2 | Protein Tyrosine Phosphatase Non-Receptor Type 2 |
| TCF7 | Transcription Factor 7 |
| TCGA | The Cancer Genome Atlas |
| TCPA | The Cancer Proteome Atlas |
| TDO | Tryptophan 2,3-dioxygenase |
| TMB | Tumor mutation burden |
| TME | Tumor microenvironment |
| VEGFA | Vascular endothelial growth factor A |
| VISTA | v-domain Ig suppressor of T-cell activation |
| VLCFA | Very-long-chain fatty acid |
| VOC | Volatile organic compound |
| WGS | Whole-genome sequencing |
| WHO | World Health Organization |